March Madness is upon us, with the first ever #16 knocking off a Number 1 see. In the midst of this true madness, Jay Rosen and myself take a look at some of the top compliance stories over the past week.
- March Madness is here. So is corruption in NCAA basketball. Tom considers both stories in Compliance Week.
- Former FCPA Unit Head Chuck Duross says that self-reporting is still “probably not worth it”. See article in GIR (sub req’d)
- Elizabeth Holmes and Theranos were engaged in massive, years long fraud. She is fined, must return her Theranos stock and is banned from running public companies for 10 years. Sam Rubenfeld reports in the WSJ Risk and Compliance Journal. See SEC Complaint for full details.
- What are some of the compliance lessons to be learned from the Novartis journey? Jaclyn Jaeger considers them in Compliance Week. (Sub req’d)
- First DPA granted under new French anti-corruption law, Sapin II. See article in NYU Compliance and Enforcement Blog.
- SFO Director David Green pushed back on the myth that DPAs are sweetheart deals in the FCPA Blog.
- Are corporate monitorships on their way out? Adam Dobrik reports in GIR (Sub req’d)
- The Trace Global Enforcement Report is out.
- On Tuesday, March 20, Tom will premier an exciting new podcast Innovation in Compliance. It is available on the FCPA Compliance Report, iTunes, Libsyn, YouTube and JDSupra.
- Tom announces presales of his next book, the Complete Compliance Handbook, which will be published by Compliance Week in April 2018. It is available for PreSale here.
- Jonathan Armstrong will be in Houston on April 10 to put on a half-day GDPR workshop. You can find out more and register at the Greater Houston Business and Ethics Roundtable website, org.
In the middle of March Madness, check out the week’s top compliance stories on This Week in FCPA.Click to tweet
For more information on how an independent monitor can help improve your company’s ethics and compliance program, visit this month’s sponsor Affiliated Monitors at www.affiliatedmonitors.com.